HLA Antigens in Japanese Patients with Systemic Lupus Erythematosus

References

• Sasazuki T, Nishimura Y, Muto M, Ohta N. HLA-linked genes controlling the immune response and disease susceptibility. Immunol Rev 1983; 70: 51–75
   PubMed Web of Science ®Google Scholar
• Charron D. Molecular basis of human leukocyte antigen class II disease associations. Adv. Immunol 1990; 48: 107–59
   Google Scholar
• Hartung K, Fontana A, Klar M, et al. Association of class I, II and III MHC gene products with systemic lupus erythematosus — results of a central European multicenter study. Rheumatol Int 1989; 9: 13–8
   PubMed Web of Science ®Google Scholar
• Ahearn J M, Provost T T, Dorsch C A, et al. Interrelationships of HLA-DR, MB, and MT phonotypes, autoantibody expression, and clinical features in systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1031–40
   PubMed Web of Science ®Google Scholar
• Kachru R B, Sequeira W, Mittal K K, Siegel M E, Telischi M. A significant increase of HLA-DR3 and DR3 in systemic lupus erythematosus among blacks. J Rheumatol 1984; 471–4
   PubMed Web of Science ®Google Scholar
• Hashimoto H, Tsuda H, Matsumoto T, et al. HLA antigens associated with systemic lupus erythematosus in Japan. J Rheumatol 1985; 12: 919–23
   PubMed Web of Science ®Google Scholar
• Mullis K B, Faloona F. Specific synthesis of DNA in vitro via a polymerasecatalyzed chain reaction. Methods Enzymol 1987; 155: 335–50
   PubMed Web of Science ®Google Scholar
• Saiki R K, Gelfand D H, Stoffel S, et al. Primer-directed enzymatic amplification of DNA with thermostable DNA polymerase. Science 1988; 239: 487–91
   PubMed Web of Science ®Google Scholar
• Dong R P, Kimura A, Numano F, et al. HLA-DP antigen and Takayasu arteritis. Tissue Antigens 1992; 39: 106–10
   PubMedGoogle Scholar
• Kimura A, Dong R P, Harada H, Sasazuki T. DNA typing of HLA II class genes in B-lympnoblastoid cell lines homozygous for HLA. Tissue Antigens 1992; 40: 5–12
   PubMedGoogle Scholar
• Bodmer J G, Marsh S GE, Albert E D, et al. Nomenclature for factors of the HLA system 1990. Tissue Antigens 1991; 37: 97–104
   PubMedGoogle Scholar
• Tan E M, Cohen A S, Fries J F, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271–7
   PubMed Web of Science ®Google Scholar
• Churg J, Sobin J H. Renal disease. Classification and atlas of glomerular diseases. “lupus nephritis”. Igaku-Shoin, Tokyo 1982; 127–49
   Google Scholar
• Tan E M, Kunkel H G. Characteristics of a soluble nuclear antigen precipitating with sera of patients with systemic lupus erythematosus. J Immunol 1966; 96: 464–71
   PubMed Web of Science ®Google Scholar
• Kurata N, Tan E M. Identification of antibodies to nuclear acidic antigens by counterimmunoelectrophoresis. Arthritis Rheum 1976; 19: 574–80
   PubMed Web of Science ®Google Scholar
• Woolf B. On estimating the relation between blood group and disease. Ann Hum Genet 1955; 19: 251–3
   PubMed Web of Science ®Google Scholar
• Mittal K K. The HLA polymorphism and susceptibility to disease. Vox Sang 1976; 31: 161–73
   PubMed Web of Science ®Google Scholar
• Imanishi T, Akaza T, Kimura A, Tokunaga K, Gojobori T. Allele frequencies and haplotype frequencies for HLA and complement loci in various ethnic groups. HLA 1991, K Tsuji, M Aizawa, T Sasazuki. Oxford University Press, Oxford 1992; Vol 1: 1065–1220
   Google Scholar
• Sakurami T, Ueno Y, Iwaki Y, Park M S, Terasaki P I. HLA-DR specificities among Japanese with several autoimmune diseases. Tissue Antigens 1982; 19: 129–33
   PubMedGoogle Scholar
• Kameda S, Naito S, Tanaka K, et al. HLA antigens of patients with systemic lupus erythematosus in Japan. Tissue Antigens 1982; 20: 221–2
   PubMedGoogle Scholar
• Sontheimer R D, Stastny P, Gilliam J N. Human histocompatibility antigen association in subacute cutaneous lupus erythematosus. J Clin Invest 1981; 67: 312–6
   PubMed Web of Science ®Google Scholar
• Schur P H, Meyer I, Garovoy M, et al. Associations between systemic lupus erythematosus and the major histocompatibility complex: Clinical and immunological considerations. Clin Immunol Immunopathol 1982; 24: 263–75
   PubMedGoogle Scholar
• Bell D A, Maddison P J. Serologic subsets in systemic lupus erythematosus. Arthritis Rheum 1980; 23: 1268–73
   PubMed Web of Science ®Google Scholar
• Alvarellos A, Ahearn J M, Provost T T, et al. Realtionship of HLA-DR and MT antigens to autoantibody expression in systemic lupus erythematosus. Arthritis Rheum 1983; 26: 1533–5
   PubMed Web of Science ®Google Scholar
• Hamilton R G, Harley J B, Bias W B, et al. Two Ro (SS-A) autoantibody responses in systemic lupus erythematosus: Correlation of HLA-DR/DQ specificities with quantitative expression of Ro (SS-A) autoantibody. Arthritis Rheum 1988; 31: 496–505
   PubMed Web of Science ®Google Scholar
• Watson R M, Lane A T, Barnett N K, Bias W B, Arnett F C, Provost T T. Neonatal lupus erythematosus: A clinical serological and immunogenetic study with review of the literature. Medicine 1984; 63: 362–8
   PubMed Web of Science ®Google Scholar
• Reveille J D, Schrohenloher R E, Acton R T, Barger B O. DNA analysis of HLA-DR and DQ genes in American Blacks with systemic lupus erythematosus. Arthritis Rheum 1989; 32: 1243–51
   PubMed Web of Science ®Google Scholar
• Reveille J D, Anderson K L, Schrohenloher R E, Acton R T, Barger B O. Restriction fragment length polymorphism analysis of HLA-DR, DQ, DP and C4 alleles in Caucasians with systemic lupus erythematosus. J Rheumatol 1991; 18: 14–8
   PubMed Web of Science ®Google Scholar
• Arnett F C, Olsen M L, Anderson K L, Reveille J D. Molecular analysis of major histocompatibility complex alleles associated with the lupus anticoagulant. J Clin Invest 1991; 87: 1490–5
   PubMed Web of Science ®Google Scholar
• Gladman D D, Terasaki P I, Park M S, et al. Increased frequency of HLA-DRw2 in SLE. Lancet 1979; 2: 902
   PubMed Web of Science ®Google Scholar
• Alarif L I, Ruppert O B, Wilson R, Jr, et al. HLA-DR antigens in blacks with rheumatoid arthritis and systemic lupus erythematosus. J Rheumatol 1983; 10: 297–300
   PubMed Web of Science ®Google Scholar
• Terasaki P I, Bernoco D, Park M S, et al. Microdroplet testing for HLA-A, -B, -C, and -D antigens. Am J Clin Pathol 1987; 69: 103–20
   Google Scholar
• Baur M P, Danilovs J A. Population analysis of HLA-A, B, C, DR, and other genetic markers. Histocompatibility Testing 1980, P I Terasaki. UCLA Tissue Typing Laboratory, Los Angeles 1980; 955–93
   Google Scholar
• Fujisaku A, Frank M B, Neas B, Reichlin M, Harley J. HLA-DQ gene complementation and other histocompatibility relationship in man with the anti-Ro/SSA autoantibody response of systemic lupus erythematosus. J CLin Invest 1990; 86: 606–11
   PubMed Web of Science ®Google Scholar
• Reveille J, Macleod M J, Whittington K, Arnett F C. Specific amino acid residues in the second hypervariable region of HLA-DQA1 and DQB1 chain genes promote the RO (SS-A)/La (SS-B) autoantibody response. J Immunol 1991; 146: 3871–6
   PubMed Web of Science ®Google Scholar
• Reinharz D, Tiercy J M, Mach B, Jeannet M. Absence of DRw15/3 and of DRw15/7 heterozygotes in Caucasian patients with systemic lupus erythematosus. Tissue Antigens 1991; 37: 10–5
   PubMedGoogle Scholar
• Fronek Z, Timmerman L A, Alper C A, et al. Major histocompatibility complex genes and susceptibility to systemic lupus erythematosus. Arthritis Rheum 1990; 33: 1542–53
   PubMed Web of Science ®Google Scholar
• Olsen M L, Arnett F C, Reveille J D. Contrasting molecular patterns of MHC Class II alleles associated with the anti-Sin and anti-RNP precipitin autoantibodies in systemic lupus erythematosus. Arthritis Rheum 1993; 36: 94–104
   PubMed Web of Science ®Google Scholar